Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular proteins and organelles of granulocytes refers to the complex internal machinery of white blood cells such as neutrophils, eosinophils, and basophils, which are characterized by the presence of specialized granules. These granules contain a variety of enzymes and antimicrobial proteins, including myeloperoxidase (MPO), proteinase 3 (PR3), and elastase, which are essential for the innate immune system's ability to neutralize pathogens (StatPearls, 2023). In the context of pathology, these intracellular components are frequently the targets of antineutrophil cytoplasmic antibodies (ANCA), leading to autoimmune disorders like granulomatosis with polyangiitis and microscopic polyangiitis (NIH, 2022). Therapeutic strategies often involve broad immunosuppression to reduce the production of these autoantibodies or, more recently, the development of specific inhibitors for individual enzymes like MPO to treat chronic inflammatory conditions (PubMed, 2021). Because this term encompasses a wide range of distinct molecular entities rather than a single receptor or enzyme, it is generally classified as a cellular compartment or a group of antigens rather than a specific drug target.
Therapeutic intervention involves broad immunosuppression to inhibit the production of autoantibodies against these proteins, or the use of specific small-molecule inhibitors to block the enzymatic activity of individual components like myeloperoxidase.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular proteins and organelles of granulocytes.